Promising 'first' in Alzheimer's drug development
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on both major aggregation-promoting 'hotspots' of the Tau protein in the brain -- a key driver of neurodegeneration.
Hosted on MSN2d
Alzheimer's disease could be stopped in its tracks by new drug with potential to 'prevent progression'This drug has the potential to be more targeted than others currently being studied, and we hope it will result in fewer ...
ScienceAlert on MSN2d
Breakthrough Alzheimer's Drug Targets Key 'Hotspots' to Suppress Toxic TanglesThe drug is RI-AG03, and it's a peptide inhibitor (a blocker of proteins). In tests on fruit flies and human cells, it has ...
Scientists have developed a novel peptide that could potentially revolutionize the treatment of Alzheimer's disease and other neurodegenerative disorders known as tauopathies.
AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
The increasing knowledge on how protein tau is organized in live cells has shown that the protein forms nanometer-sized ...
A new drug targeting Tau protein shows promise in preventing its accumulation, potentially leading to more effective ...
Dr Anthony Aggidis, a former Postdoctoral Research Associate at Lancaster University, led the study of the drug RI-AG03.
6don MSN
An international team of researchers led by Lancaster University has made a promising breakthrough in the development of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback